This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ehrlich, P., and Morgenroth, J., Ber. Klin. Wchschr., 21, 453 (1900).
Burnet, F. M., The Clonal Selection Theory of Acquired Immunity (Vanderbilt Univ. Press, Nashville, Tenn., 1959).
Owen, R. D., Science, 102, 400 (1945).
Billingham, R. E., Brent, L., and Medawar, P. B., Phil. Trans. Roy. Soc., B, 239, 357 (1956).
Chase, M. W., Ann. Rev. Microbiol., 13, 349 (1959).
Mitchison, N. A., Immunol., 5, 341 (1962).
Dresser, D. W., Immunol., 5, 378 (1962).
Sercarz, E. E., and Coons, A. H., J. Immunol., 90, 478 (1963); Nature, 184, 1080 (1959).
Siskind, G. W., Paterson, P. Y., and Thomas, L., J. Immunol., 90, 929 (1963).
That is, antibody with the same specificity at each of the two sites in the molecule.
Because of the low level of antibody with which we are concerned in the initial phase of the immune response, the concentrations of complexes molar ratios of antibody to antigen greater than one will be negligible. The fact that in antibody-excess complexes of this kind (AgAb n; n > 1) the immunogenicity of th antigen is reduced, or even abolished entirely (refs. 12, 13), is not relevant to this part of the present discussion. However, complexes of the Ab-excess type could provide an important source of control for limiting the amount of antibody formed against one antigen. That is, when antibody-levels become of sufficient magnitude, antibody-excess complexes would be expected to reduce, or eliminate, the antigen's immunogenicity and to hasten its elimination Teleonomically speaking, such a control mechanism could protect an animal trom committing so much of its antibody-forming capacity to one antigen that it is unable to respond to other antigens.
Uhr, J. W., and Baumann, J. B., J. Exp. Med., 113, 935 (1961).
Downie, A. W., Glenny, A. T., Parish, H. J., Smith, W., and Wilson, G. S., Brit. Med. J., ii, 717 (1941).
Glenny, A. T., and Hopkins, B. E., J. Hygiene, 21, 142 (1923).
Terres, G., and Wolins, W., Proc. Soc. Exp. Biol. and Med., 102, 632 (1959).
Segre, D., and Kaeberle, M. L., J. Immunol., 89, 782 (1962).
Monod, J., Changeaux, J.-P., and Jacob, F. J., J. Mol. Biol., 6, 306 (1963).
Haurowitz, F., and Schwerin, P., J. Immunol., 47, 111 (1943).
Eisen, H. N., Carsten, M. E., and Belman, S., J. Immunol., 73, 296 (1954).
Nisonoff, A., Winkler, M. H., and Pressman, D., J. Immunol., 82, 201 (1959).
Smith, R. T., Adv. Immunol., 1, 67 (1961).
In view of the importance ascribed to bivalence it is necessary to consider the possible role of monovalent antibody. The monovalence of antibody is not an established experimental fact. The view that such antibody exists, although not incompatible with our present knowledge, is nevertheless an unwarranted inference from the existence of non-precipitating antibody. In addition, it is not necessary to our hypothesis that every antibody molecule be able to form an inductive complex. As is suggested by the differences between blocking and skin-sensitizing antibodies in human allergy, and between γ2 and γ1 7S guinea pig antibodies (refs. 22, 23), different antibody molecules directed against the same antigenic determinant may differ in their capacity for cellular attachment.
Fireman, P., Vannier, W. E., and Goodman, H. C., J. Exp. Med., 117, 603. (1963).
Ovary, Z., Benacerraf, B., and Bloch, K. J., J. Exp. Med., 117, 951 (1963).
Pauling, L., J. Amer. Chem. Soc., 62, 2643 (1940).
Lederberg, J., Science, 129, 1649 (1959).
Karush, F., in Immunochemical Approaches to Problems in Microbiology, edit. by Heidelberger, M., and Plescia, O. J. (Rutgers Univ. Press, New Brunswick, New Jersey, 1961).
Hoerlein, A. B., J. Immunol., 78, 112 (1957).
Jerne, N. K., Proc. U.S. Nat. Acad. Sci., 41, 849 (1955).
Boyden, S. V., Nature, 185, 724 (1960).
Uhr, J. W., Finklestein, M. S., and Baumann, J. B., J. Exp. Med., 115, 655 (1962).
Karush, F., Adv. Immunol., 2, 1 (1962).
Thorbecke, G. J., Siskind, G. W., and Goldberger, N., J. Immunol., 87, 147 (1961).
Terres, G., and Hughes, W. L., J. Immunol., 83, 459 (1959).
Martinez, C., Smith, J. M., Blaese, M., and Good, R. A., J. Exp. Med., 118, 743 (1963).
Main, J. M., and Prehn, R. T., J. Nat. Cancer Inst., 15, 1023 (1955).
Schwartz, R. S., and Dameshek, W., J. Immunol., 90, 703 (1963).
Martinez, C., Shapiro, F., Kelman, H., Onstad, T., and Good, R. A., Proc. Soc. Exp. Biol. and Med., 103, 266 (1960).
Martinez, C., Smith, J. M., Blaese, M., and Good, R. A., Fed. Proc., 22, 441 (1963).
Smith, R. T., and Bridges, R. A., J. Exp. Med., 108, 227 (1958).
McMaster, P. D., and Kruse, H., J. Exp. Med., 94, 323 (1951).
Garvey, J. S., and Campbell, D. H., J. Exp. Med., 105, 361 (1957).
Cohen, S., Halloway, R. C., Matthews, C., and McFarlane, A. S., Biochem. J., 62, 133 (1956).
Berson, S. A., Yalow, R. S., Schreiber, S. S., and Post, J., J. Clin. Invest., 32, 746 (1953).
Cinader, B., and Dubert, J. M., Proc. Roy. Soc., B, 146, 18 (1956).
Weigle, W. O., J. Exp. Med., 114, 111 (1961).
Newton, W. T., Fed. Proc., 22, 440 (1963).
Curtin, C. C., Brit. J. Exp. Path., 40, 255 (1958).
Bussard, A., and Hannoun, C., Nature, 194, 881 (1962).
Kaplan, M., J. Immunol., 80, 254, 268 (1958).
Nossal, G. J. V., Adv. Immunol., 2, 163 (1962).
Urso, P., and Makinodan, T., J. Immunol., 90, 897 (1963).
Harris, T. N., and Harris, S., in Mechanisms of Hypersensitivity, edit. by Shaffer, J. H., LoGrippo, G. A., and Chase, M. W., 575 (Little, Brown and Co., Boston, 1959).
Najarian, J. S., and Feldman, J. D., J. Exp. Med., 115, 1083 (1962).
Karush, F., and Eisen, H. N., Science, 136, 1032 (1962).
Dixon, F. J., and Maurer, P., J. Exp. Med., 101, 245 (1955).
Mitchison, N. A., in Mechanism of Immunological Tolerance, 245 (Czech. Acad. Sci., Prague, 1962).
Billingham, R. E., Silvers, W. K., and Wilson, D. B., J. Exp. Med., 118, 397 (1963).
Simonsen, M., in Mechanisms of Immunological Tolerance (Czech. Acad. Sci., Prague, 1962).
Hilgard, H., Burnet, D., and Burnet, F. M., Austral. J. Exp. Biol. And Med., 40, 233 (1962).
Martinez, C., Shapiro, F., and Good, R. A., Proc. Soc. Exp. Biol. and Med., 107, 553 (1961).
Argyris, B. F., J. Immunol., 90, 29 (1963).
Mitchison, N. A. (personal communication).
Dietrich, F. M., and Weigle, W. O. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
EISEN, H., KARUSH, F. Immune Tolerance and an Extracellular Regulatory Role for Bivalent Antibody. Nature 202, 677–682 (1964). https://doi.org/10.1038/202677a0
Issue Date:
DOI: https://doi.org/10.1038/202677a0
This article is cited by
-
Immunological Tolerance as the Result of Terminal Differentiation of Immunologically Competent Cells
Nature (1966)
-
Experimentelle Gesichtspunkte zur Organtransplantation
Klinische Wochenschrift (1966)
-
Prevention of Immunological Tolerance to Shigella Antigens in New-born Mice by Immune Spleen Cell Extracts
Nature (1965)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.